Dr Reddy’s to Start Importing Russia-made Sputnik V Vaccine in April-June, Price under Consideration

It will start this quarter, via the imported route and the availability will be ramped up next quarter once the Made in India Sputnik V comes on stream. Discussions with the government and other stakeholders on pricing are under way, the Hyderabad-based pharma major’s senior leadership said on Wednesday.

The contract with Russian Direct Investment Fund (RDIF), which has partnered Dr. Reddy’s for clinical trials and distribution, is 250 million vaccine units (125 million people doses). This number is extendable, CEO of API and Services business Deepak Sapra said.

Separately, the RDIF has entered into production pacts with six vaccine makers in the country, he said. About 60-70% of the global volumes of Sputnik V will be made in India. Most of it will be used in the country, he said, adding Sputnik is being made in Russia and a few other countries.